Screener
10x Genomics, Inc. TXG Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Single Cell | $88.45M+3.1% | $88.89M+5.7% | —— | $92.52M-4.2% | $85.79M-8.8% | |
| License and royalty revenue | $1.94M-93.0% | $947K-94.4% | $341K+207% | $983K+935% | $27.75M+24,243% | |
| Products and services revenue | $149.09M+2.7% | $149.9M+8.8% | $165.69M+0.5% | $148.02M-2.3% | $145.16M-5.1% | |
| Services | $10.68M+26.0% | $8.83M+15.4% | $8.47M+20.6% | $8.13M+29.0% | $8.48M+46.7% | |
| Single Cell | $3.09M-46.1% | $5.22M-11.7% | —— | $4.93M-35.5% | $5.73M-34.9% | |
| Spatial | $4.57M-47.8% | $6.04M-32.2% | $9.36M-30.2% | $7.07M-38.0% | $8.77M-41.8% | |
| Revenue by Geography | ||||||
| Americas (excluding United States) | $2.92M+9.4% | $3.41M-9.2% | $3.22M+9.6% | $2.63M-15.3% | $2.67M-22.0% | |
| Asia-Pacific (excluding China) | $11.07M+25.1% | $18.06M+16.2% | $15.37M+15.0% | $12.32M+12.5% | $8.85M-0.8% | |
| China | $14.97M-35.4% | $15.84M-6.2% | $15.02M+2.8% | $15.19M+1.1% | $23.17M+68.7% | |
| Europe, Middle East and Africa | $39.97M+15.1% | $36.85M+15.5% | $53.46M+7.3% | $41.62M+10.0% | $34.73M-7.0% | |
| United States | $82.11M-20.7% | $76.69M-11.7% | $78.96M-6.3% | $77.25M-8.8% | $103.49M+15.4% |
FAQ
- How does 10x Genomics, Inc. break its business down?
- 10x Genomics, Inc. (TXG) reports revenue by product across 6 parts — Single Cell, License and royalty revenue, Products and services revenue, Services and Single Cell. Each is extracted from the segment footnotes and tracked over time.
- Where does 10x Genomics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in 10x Genomics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
